Cost-effectiveness analysis of fosaprepitant versus aprepitant-based antiemetic regimens in children receiving highly emetogenic chemotherapy: individual patient-level analysis of a randomised trial.
- DOI
- 10.1136/spcare-2026-006355
- Published
- 2026 Aug 27
- Container
- BMJ supportive & palliative care
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/spcare-2026-006355,
title = {Cost-effectiveness analysis of fosaprepitant versus aprepitant-based antiemetic regimens in children receiving highly emetogenic chemotherapy: individual patient-level analysis of a randomised trial.},
author = {Kumar R and Sra MS and Rasheed AA and Sasi A and Pushpam D and Batra A and Ganguly S and Bakhshi S},
year = {2026},
journal = {BMJ supportive \& palliative care},
doi = {10.1136/spcare-2026-006355},
url = {https://doi.org/10.1136/spcare-2026-006355}
}RIS
TY - JOUR TI - Cost-effectiveness analysis of fosaprepitant versus aprepitant-based antiemetic regimens in children receiving highly emetogenic chemotherapy: individual patient-level analysis of a randomised trial. AU - Kumar R AU - Sra MS AU - Rasheed AA AU - Sasi A AU - Pushpam D AU - Batra A AU - Ganguly S AU - Bakhshi S PY - 2026 JO - BMJ supportive & palliative care DO - 10.1136/spcare-2026-006355 UR - https://doi.org/10.1136/spcare-2026-006355 ER -
APA
R, K., MS, S., AA, R., A, S., D, P., A, B., S, G., & S, B. (2026). Cost-effectiveness analysis of fosaprepitant versus aprepitant-based antiemetic regimens in children receiving highly emetogenic chemotherapy: individual patient-level analysis of a randomised trial.. BMJ supportive & palliative care. https://doi.org/10.1136/spcare-2026-006355
Source records
- pubmed · retrieved 2026-09-25T22:07:48.760Z
- europe-pmc · retrieved 2026-09-25T22:07:48.819Z